Chevron enters the back half of May with short sellers in full retreat and the broader energy complex charging higher — a combination that has pushed the stock up more than 5% on the week to $191.10.
The most telling shift in positioning is the speed of the short unwind. Short interest has dropped 26% over the past month, falling from around 24 million shares in early April to roughly 18 million now, equivalent to less than 0.9% of the free float. That number alone would normally not merit much attention on a mega-cap. What makes it interesting here is the scale of the reversal: shorts were building aggressively through the April tariff-driven selloff, and those positions are now being unwound just as fast. The borrow market tells a similar story — availability is extremely loose, with costs running at just 0.35% annually and showing no sign of stress. This is not a stock where the lending market is generating any friction for short sellers; the exit has been orderly and cheap.
Options positioning is leaning mildly bullish, though not dramatically so. The put/call ratio has eased to 0.75, slightly below its 20-day average of 0.78, and the z-score of -0.81 suggests nothing extreme in either direction. The 52-week range on the PCR runs from 0.60 to 0.93, so current readings sit near the middle — call demand has edged ahead of puts, but this reads more as a relaxing of prior caution than any aggressive directional bet. The week's macro tailwinds have clearly helped; close peers and added 9.2% and 7.5% respectively, and surged 12.4% — CVX's 5.2% gain actually looks modest by sector comparison.
The Street is broadly constructive, though recent moves have been mixed at the edges. Targets from UBS and RBC Capital sit at $220, and Wells Fargo carried its target to $222 in early April. The more cautious signal came this week from Bernstein, which held its Market Perform rating but trimmed its target from $216 to $204 — still well above the current price, but a rare downward revision in a month that otherwise saw most firms nudging higher. The mean price target of $215 implies about 12% upside from current levels, a reasonable but not stretched premium. Valuation has compressed modestly on a 30-day basis — the P/E multiple has eased to around 14.2x — but EV/EBITDA has also softened, sitting near 6.4x. On factor scores, CVX ranks particularly well on dividend quality (97th percentile) and EPS momentum (85th percentile on both 30- and 90-day measures), while the short score of 28.2 signals a low short-selling conviction environment — consistent with what the raw data shows.
Insider activity adds a note of caution worth flagging. Director John B. Hess sold approximately $36 million worth of shares on May 6, across three transactions. That follows earlier March sales by CEO Mike Wirth (around $30 million) and CLO Hew Pate. The net insider position over the past 90 days works out to a small net positive in share terms — but that headline figure masks a pattern of steady selling by named officers at prices between $183 and $213. These are not token transactions. Whether they reflect personal diversification or something more considered, the direction is consistent and the dollar values are material for a single-name read.
The next event to watch is Chevron's earnings call on May 27. The most recent print on May 1 saw the stock fall 0.5% on the day and 6% over the following week — a meaningful reaction. Before that, in January, it rose 1.7% on the day and 5.6% over five days. With short interest at a multi-month low and the stock trading close to the midpoint of analyst targets, how management frames the commodity outlook and capital return cadence will determine whether the current short unwind was well-timed or premature.
See the live data behind this article on ORTEX.
Open CVX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
